Causal association of education, smoking, sedentary lifestyle and body mass index with disc degeneration: Mendelian randomization
Although significant progress in the development of immunotherapy over the past two decades (2), approximately 50% of IBD patients show response failure after initial advanced therapies, with response rates exhibiting a further decline for second- and third-line treatments (3, 4)
Starting laser before beginning anti-androgen treatment
During GLP-1associated weight loss, lean-mass changes are typically adaptive and preventable , not degenerative. GLP-1 Body Composition Changes: What Clinical Trials Show About Muscle Loss Clinical trials and body-composition sub-studies of semaglutide and tirzepatide consistently demonstrate: Fat mass accounts for most weight lost during treatment. Lean mass may decrease , particularly without resistance training or adequate protein intake. In many patients, the proportion of lean mass relative to total body weight is preserved or improved , because fat loss exceeds lean loss. Key clinical insight: GLP-1/GIP therapies improve overall body composition by preferentially reducing fat massnot by causing muscle breakdown. Lean mass refers to all the non-fat tissues in the bodyprimarily skeletal muscle , but also organs, bones, connective tissue, and body waterthat support metabolism, movement, and overall physical function

Glucagon-like peptide-1 receptor (GLP-1R) agonists are effective anti-obesity drugs but their use is limited by side effects
Frequently Asked Questions About Progestogen Hypersensitivity Is autoimmune progesterone dermatitis rare